Shares of Direxion HCM Tactical Enhanced U.S. ETF (NYSEARCA:HCMT – Get Free Report) hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $43.26 and last traded at $43.2590, with a volume of 8574 shares traded. The stock had previously closed at $41.36.
Direxion HCM Tactical Enhanced U.S. ETF Stock Down 0.5%
The company has a market cap of $633.94 million, a P/E ratio of 21.26 and a beta of 1.63. The stock has a 50 day moving average price of $40.70 and a two-hundred day moving average price of $39.31.
Institutional Trading of Direxion HCM Tactical Enhanced U.S. ETF
A number of institutional investors have recently bought and sold shares of HCMT. Integrated Wealth Concepts LLC acquired a new stake in Direxion HCM Tactical Enhanced U.S. ETF during the second quarter worth approximately $26,000. NFSG Corp acquired a new position in Direxion HCM Tactical Enhanced U.S. ETF in the first quarter valued at about $33,000. World Investment Advisors bought a new stake in Direxion HCM Tactical Enhanced U.S. ETF during the fourth quarter worth about $224,000. Axxcess Wealth Management LLC grew its stake in Direxion HCM Tactical Enhanced U.S. ETF by 6.2% during the fourth quarter. Axxcess Wealth Management LLC now owns 5,877 shares of the company’s stock worth $227,000 after buying an additional 344 shares in the last quarter. Finally, Tucker Asset Management LLC bought a new position in Direxion HCM Tactical Enhanced U.S. ETF in the 2nd quarter valued at about $568,000.
About Direxion HCM Tactical Enhanced U.S. ETF
The Direxion HCM Tactical Enhanced US ETF (HCMT) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed fund-of-funds that toggles between a 200% leveraged US equity position and a 100% investment to cash or cash equivalents based on a proprietary tactical indicator that identifies broad trends in the US equity markets. HCMT was launched on Jun 22, 2023 and is managed by Direxion.
Featured Stories
- Five stocks we like better than Direxion HCM Tactical Enhanced U.S. ETF
- Lockheed’s Stock Hasn’t Priced In Its Own Backlog—Boeing’s Might Already Have
- Eli Lilly Keeps Pulling Ahead—Can Novo Nordisk Catch Up?
- Old Dogs, New Tech: 3 Legacy Stocks Powering the AI Boom
- 3 Tech Stocks Positioned for More Upside if the Sector’s Breakout Holds
Receive News & Ratings for Direxion HCM Tactical Enhanced U.S. ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion HCM Tactical Enhanced U.S. ETF and related companies with MarketBeat.com's FREE daily email newsletter.
